Holmlund J - Search Results

1

A phase I/II study of LY900003, an antisense inhibitor of protein kinase C-alpha, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer.

Villalona-Calero MA, Ritch P, Figueroa JA, Otterson GA, Belt R, Dow E, George S, Leonardo J, McCachren S, Miller GL, Modiano M, Valdivieso M, Geary R, Oliver JW, Holmlund J. Villalona-Calero MA, et al. Among authors: holmlund j. Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6086-93. doi: 10.1158/1078-0432.CCR-04-0779. Clin Cancer Res. 2004. PMID: 15447994 Clinical Trial.

2

Phase I clinical and pharmacokinetic study of protein kinase C-alpha antisense oligonucleotide ISIS 3521 administered in combination with 5-fluorouracil and leucovorin in patients with advanced cancer.

Mani S, Rudin CM, Kunkel K, Holmlund JT, Geary RS, Kindler HL, Dorr FA, Ratain MJ. Mani S, et al. Among authors: holmlund jt. Clin Cancer Res. 2002 Apr;8(4):1042-8. Clin Cancer Res. 2002. PMID: 11948111 Clinical Trial.

3

A phase I trial of ISIS 2503, an antisense inhibitor of H-ras, in combination with gemcitabine in patients with advanced cancer.

Adjei AA, Dy GK, Erlichman C, Reid JM, Sloan JA, Pitot HC, Alberts SR, Goldberg RM, Hanson LJ, Atherton PJ, Watanabe T, Geary RS, Holmlund J, Dorr FA. Adjei AA, et al. Among authors: holmlund j. Clin Cancer Res. 2003 Jan;9(1):115-23. Clin Cancer Res. 2003. PMID: 12538459 Clinical Trial.

4

Phase II randomized study of ISIS 3521 and ISIS 5132 in patients with locally advanced or metastatic colorectal cancer: a National Cancer Institute of Canada clinical trials group study.

Cripps MC, Figueredo AT, Oza AM, Taylor MJ, Fields AL, Holmlund JT, McIntosh LW, Geary RS, Eisenhauer EA. Cripps MC, et al. Among authors: holmlund jt. Clin Cancer Res. 2002 Jul;8(7):2188-92. Clin Cancer Res. 2002. PMID: 12114419 Clinical Trial.

5

Phase I Trial of ISIS 5132, an antisense oligonucleotide inhibitor of c-raf-1, administered by 24-hour weekly infusion to patients with advanced cancer.

Rudin CM, Holmlund J, Fleming GF, Mani S, Stadler WM, Schumm P, Monia BP, Johnston JF, Geary R, Yu RZ, Kwoh TJ, Dorr FA, Ratain MJ. Rudin CM, et al. Among authors: holmlund j. Clin Cancer Res. 2001 May;7(5):1214-20. Clin Cancer Res. 2001. PMID: 11350886 Clinical Trial.

6

Phase I evaluation of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C-alpha, in patients with advanced cancer.

Nemunaitis J, Holmlund JT, Kraynak M, Richards D, Bruce J, Ognoskie N, Kwoh TJ, Geary R, Dorr A, Von Hoff D, Eckhardt SG. Nemunaitis J, et al. Among authors: holmlund jt. J Clin Oncol. 1999 Nov;17(11):3586-95. doi: 10.1200/JCO.1999.17.11.3586. J Clin Oncol. 1999. PMID: 10550158 Clinical Trial.

7

Phase I study of an antisense oligonucleotide to protein kinase C-alpha (ISIS 3521/CGP 64128A) in patients with cancer.

Yuen AR, Halsey J, Fisher GA, Holmlund JT, Geary RS, Kwoh TJ, Dorr A, Sikic BI. Yuen AR, et al. Among authors: holmlund jt. Clin Cancer Res. 1999 Nov;5(11):3357-63. Clin Cancer Res. 1999. PMID: 10589745 Clinical Trial.

8

A phase I trial of c-Raf kinase antisense oligonucleotide ISIS 5132 administered as a continuous intravenous infusion in patients with advanced cancer.

Cunningham CC, Holmlund JT, Schiller JH, Geary RS, Kwoh TJ, Dorr A, Nemunaitis J. Cunningham CC, et al. Among authors: holmlund jt. Clin Cancer Res. 2000 May;6(5):1626-31. Clin Cancer Res. 2000. PMID: 10815879 Clinical Trial.

9

A phase I trial of aprinocarsen (ISIS 3521/LY900003), an antisense inhibitor of protein kinase C-alpha administered as a 24-hour weekly infusion schedule in patients with advanced cancer.

Advani R, Lum BL, Fisher GA, Halsey J, Geary RS, Holmlund JT, Kwoh TJ, Dorr FA, Sikic BI. Advani R, et al. Among authors: holmlund jt. Invest New Drugs. 2005 Oct;23(5):467-77. doi: 10.1007/s10637-005-2906-0. Invest New Drugs. 2005. PMID: 16133798 Clinical Trial.

10

A Phase I trial of H-ras antisense oligonucleotide ISIS 2503 administered as a continuous intravenous infusion in patients with advanced carcinoma.

Cunningham CC, Holmlund JT, Geary RS, Kwoh TJ, Dorr A, Johnston JF, Monia B, Nemunaitis J. Cunningham CC, et al. Among authors: holmlund jt. Cancer. 2001 Sep 1;92(5):1265-71. doi: 10.1002/1097-0142(20010901)92:5<1265::aid-cncr1447>3.0.co;2-5. Cancer. 2001. PMID: 11571742 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters